Grimes & Company »

Arrowhead Pharmaceuticals shares owned by Grimes & Company

Quarter-by-quarter ownership of Arrowhead Pharmaceuticals (ARWR) shares owned by Grimes & Company from 13F filings

Historical chart of Grimes & Company investment in Arrowhead Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Arrowhead Pharmaceuticals held by Grimes & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrowhead Pharmaceuticals by Grimes & Company

Quarter filed Position value Share count Share price at filing
2025-12-31 $295k 4.4k 66.39

More positions owned by Grimes & Company

Ishares Tr Core Msci Eafe (IEFA)
Vanguard Index Fds Small Cp Etf (VB)
Ishares Tr Core S&p500 Etf (IVV)
Spdr Series Trust State Street Spd (SJNK)
Ishares Tr Broad Usd High (USHY)
Spdr Series Trust State Street Spd (SPHY)
Ishares Core Msci Emkt (IEMG)
Select Sector Spdr Tr State Street Tec (XLK)
John Hancock Exchange Traded Mltfctr Lrg Cap (JHML)
Apple (AAPL)
Microsoft Corporation (MSFT)
Select Sector Spdr Tr State Street Com (XLC)
Select Sector Spdr Tr State Street Hea (XLV)
NVIDIA Corporation (NVDA)
Vanguard Index Fds Growth Etf (VUG)

View all positions for Grimes & Company

Top funds holding Arrowhead Pharmaceuticals

BlackRock
Vanguard Group
venBio Select Advisor
State Street Corporation
FMR
Geode Capital Management
Slate Path Capital
Driehaus Capital Management
Arrowstreet Capital, Limited Partnership
Deerfield Management Company
Norges Bank Investment Management
Goldman Sachs Group
Baker Bros. Advisors
Siren
Charles Schwab Investment Management

View all funds holding Arrowhead Pharmaceuticals